Euba B et al. |
Relationship between azithromycin susceptibility and administration efficacy for nontypeable Haemophilus influenzae respiratory infection. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25712355
|
Shigemura K et al. |
Azithromycin resistance and its mechanism in Neisseria gonorrhoeae strains in Hyogo, Japan. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25712352
|
Liu P et al. |
Comparative pharmacokinetics of azithromycin in serum and white blood cells of healthy subjects receiving a single-dose extended-release regimen versus a 3-day immediate-release regimen. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17060516
|
Soltow SM and Brenner GM |
Synergistic activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17060522
|
Donowitz GR and Earnhardt KI |
Azithromycin inhibition of intracellular Legionella micdadei. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8285604
|
Strickman D et al. |
In vitro effectiveness of azithromycin against doxycycline-resistant and -susceptible strains of Rickettsia tsutsugamushi, etiologic agent of scrub typhus. |
1995 |
Antimicrob. Agents Chemother. |
pmid:8585717
|
Rodvold KA et al. |
Steady-state plasma and bronchopulmonary concentrations of intravenous levofloxacin and azithromycin in healthy adults. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12878504
|
Dunne MW et al. |
Efficacy of single-dose azithromycin in treatment of acute otitis media in children after a baseline tympanocentesis. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12878537
|
Batt SL et al. |
Impact of azithromycin administration for trachoma control on the carriage of antibiotic-resistant Streptococcus pneumoniae. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12936971
|
Henry DC et al. |
Randomized double-blind study comparing 3- and 6-day regimens of azithromycin with a 10-day amoxicillin-clavulanate regimen for treatment of acute bacterial sinusitis. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12936972
|
Kohlhoff SA et al. |
In vitro activity of AZD0914, a novel DNA gyrase inhibitor, against Chlamydia trachomatis and Chlamydia pneumoniae. |
2014 |
Antimicrob. Agents Chemother. |
pmid:25288086
|
Grinwis ME et al. |
Macrolide and clindamycin resistance in Streptococcus milleri group isolates from the airways of cystic fibrosis patients. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20404127
|
Conte JE et al. |
Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8807050
|
Nash KA and Inderlied CB |
Rapid detection of mutations associated with macrolide resistance in Mycobacterium avium complex. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8807078
|
Loreto ES et al. |
New insights into the in vitro susceptibility of Pythium insidiosum. |
2014 |
Antimicrob. Agents Chemother. |
pmid:25223997
|
Phimda K et al. |
Doxycycline versus azithromycin for treatment of leptospirosis and scrub typhus. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17638700
|
Schmalstieg AM et al. |
The antibiotic resistance arrow of time: efflux pump induction is a general first step in the evolution of mycobacterial drug resistance. |
2012 |
Antimicrob. Agents Chemother. |
pmid:22751536
|
Wildfeuer A et al. |
Uptake of azithromycin by various cells and its intracellular activity under in vivo conditions. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8787883
|
Bosnar M et al. |
Cellular uptake and efflux of azithromycin, erythromycin, clarithromycin, telithromycin, and cethromycin. |
2005 |
Antimicrob. Agents Chemother. |
pmid:15917536
|
Neoh CF et al. |
Rapid and sensitive liquid chromatography/mass spectrometry assay for caspofungin in human aqueous humor. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20660672
|
Michot JM et al. |
Active efflux of ciprofloxacin from J774 macrophages through an MRP-like transporter. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15215125
|
Hoberman A and Paradise JL |
Study design questions in treatment of children with acute otitis media. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15215151
|
Girgis NI et al. |
Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10348767
|
Wolf K and Malinverni R |
Effect of azithromycin plus rifampin versus that of azithromycin alone on the eradication of Chlamydia pneumoniae from lung tissue in experimental pneumonitis. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10348778
|
Ngo LY et al. |
Pharmacokinetics of azithromycin administered alone and with atovaquone in human immunodeficiency virus-infected children. The ACTG 254 Team. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10348786
|
Gorby GL and McGee ZA |
Antimicrobial interference with bacterial mechanisms of pathogenicity: effect of sub-MIC azithromycin on gonococcal piliation and attachment to human epithelial cells. |
1990 |
Antimicrob. Agents Chemother. |
pmid:1982402
|
Wierzbowski AK et al. |
Expression of the mef(E) gene encoding the macrolide efflux pump protein increases in Streptococcus pneumoniae with increasing resistance to macrolides. |
2005 |
Antimicrob. Agents Chemother. |
pmid:16251306
|
Jesus FP et al. |
In vitro synergism observed with azithromycin, clarithromycin, minocycline, or tigecycline in association with antifungal agents against Pythium insidiosum. |
2014 |
Antimicrob. Agents Chemother. |
pmid:25001300
|
Gordillo ME et al. |
In vitro activity of azithromycin against bacterial enteric pathogens. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8390813
|
Miura Y et al. |
Maternal intravenous treatment with either azithromycin or solithromycin clears Ureaplasma parvum from the amniotic fluid in an ovine model of intrauterine infection. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24982089
|
Singh S et al. |
Antimycobacterial drugs modulate immunopathogenic matrix metalloproteinases in a cellular model of pulmonary tuberculosis. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24890593
|
Waites KB et al. |
In Vitro Activities of Omadacycline (PTK 0796) and Other Antimicrobial Agents against Human Mycoplasmas and Ureaplasmas. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27671057
|
Johnson MM et al. |
Effect of carbon dioxide on testing of susceptibilities of respiratory tract pathogens to macrolide and azalide antimicrobial agents. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10428903
|
Credito KL et al. |
Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10428930
|
Kobuchi S et al. |
Transport of Azithromycin into Extravascular Space in Rats. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27600045
|
Unemo M et al. |
First three Neisseria gonorrhoeae isolates with high-level resistance to azithromycin in Sweden: a threat to currently available dual-antimicrobial regimens for treatment of gonorrhea? |
2014 |
Antimicrob. Agents Chemother. |
pmid:24189248
|
Li H et al. |
Meta-analysis of the adverse effects of long-term azithromycin use in patients with chronic lung diseases. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24189261
|
Gillis RJ et al. |
Molecular basis of azithromycin-resistant Pseudomonas aeruginosa biofilms. |
2005 |
Antimicrob. Agents Chemother. |
pmid:16127063
|
Navarro G et al. |
Image-based 384-well high-throughput screening method for the discovery of skyllamycins A to C as biofilm inhibitors and inducers of biofilm detachment in Pseudomonas aeruginosa. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24295976
|
RÃos AM et al. |
Microbiologic and immunologic evaluation of a single high dose of azithromycin for treatment of experimental Mycoplasma pneumoniae pneumonia. |
2005 |
Antimicrob. Agents Chemother. |
pmid:16127085
|
Binet R et al. |
Impact of azithromycin resistance mutations on the virulence and fitness of Chlamydia caviae in guinea pigs. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20065052
|
Blais J et al. |
Inhibition of Toxoplasma gondii protein synthesis by azithromycin. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8215287
|
Dever LL et al. |
Comparative in vitro activities of clarithromycin, azithromycin, and erythromycin against Borrelia burgdorferi. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8215288
|
Edelstein PH and Edelstein MA |
In vitro activity of azithromycin against clinical isolates of Legionella species. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1849708
|
Ohara T et al. |
Effects of azithromycin on shiga toxin production by Escherichia coli and subsequent host inflammatory response. |
2002 |
Antimicrob. Agents Chemother. |
pmid:12384353
|
Berry V et al. |
Comparative bacteriological efficacy of pharmacokinetically enhanced amoxicillin-clavulanate against Streptococcus pneumoniae with elevated amoxicillin MICs and Haemophilus influenzae. |
2005 |
Antimicrob. Agents Chemother. |
pmid:15728883
|
GarcÃa-Quintanilla M et al. |
Inhibition of LpxC Increases Antibiotic Susceptibility in Acinetobacter baumannii. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27270288
|
Clark CL et al. |
Capability of 11 antipneumococcal antibiotics to select for resistance by multistep and single-step methodologies. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17876003
|
Köhler T et al. |
Ribosome protection prevents azithromycin-mediated quorum-sensing modulation and stationary-phase killing of Pseudomonas aeruginosa. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17876004
|
Itaqui SR et al. |
In Vitro Synergism between Azithromycin or Terbinafine and Topical Antimicrobial Agents against Pythium insidiosum. |
2016 |
Antimicrob. Agents Chemother. |
pmid:27216049
|
Matic V et al. |
Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15504828
|
Kosowska K et al. |
Activities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae. |
2004 |
Antimicrob. Agents Chemother. |
pmid:15504829
|
Berry V et al. |
Bacteriological efficacies of three macrolides compared with those of amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9835514
|
Spangler SK et al. |
Effect of CO2 on susceptibilities of anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8192445
|
Stamler DA et al. |
Azithromycin pharmacokinetics and intracellular concentrations in Legionella pneumophila-infected and uninfected guinea pigs and their alveolar macrophages. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8192446
|
Biedenbach DJ et al. |
Determination of CEM-101 activity tested against clinical isolates of Neisseria meningitidis from a worldwide collection. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20625152
|
Piesman J et al. |
Efficacy of an experimental azithromycin cream for prophylaxis of tick-transmitted lyme disease spirochete infection in a murine model. |
2014 |
Antimicrob. Agents Chemother. |
pmid:24165183
|
Nahata MC et al. |
Pharmacokinetics of azithromycin in pediatric patients with acute otitis media. |
1995 |
Antimicrob. Agents Chemother. |
pmid:7486938
|
Bastian S et al. |
Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21135185
|
Chisholm SA et al. |
High-level azithromycin resistance occurs in Neisseria gonorrhoeae as a result of a single point mutation in the 23S rRNA genes. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20585125
|
Ouyang-Latimer J et al. |
In vitro antimicrobial susceptibility of bacterial enteropathogens isolated from international travelers to Mexico, Guatemala, and India from 2006 to 2008. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21115800
|
Fischer JH et al. |
Influence of body weight, ethnicity, oral contraceptives, and pregnancy on the pharmacokinetics of azithromycin in women of childbearing age. |
2012 |
Antimicrob. Agents Chemother. |
pmid:22106226
|
Jepras RI et al. |
Rapid assessment of antibiotic effects on Escherichia coli by bis-(1,3-dibutylbarbituric acid) trimethine oxonol and flow cytometry. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9303401
|
Reveneau N et al. |
Bactericidal activity of first-choice antibiotics against gamma interferon-induced persistent infection of human epithelial cells by Chlamydia trachomatis. |
2005 |
Antimicrob. Agents Chemother. |
pmid:15855497
|
Deshpande D et al. |
Azithromycin Dose To Maximize Efficacy and Suppress Acquired Drug Resistance in Pulmonary Mycobacterium avium Disease. |
2016 |
Antimicrob. Agents Chemother. |
pmid:26810646
|
Heifets L et al. |
Mycobacterium avium strains resistant to clarithromycin and azithromycin. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8031351
|
Vazifeh D et al. |
Cellular accumulation of the new ketolide RU 64004 by human neutrophils: comparison with that of azithromycin and roxithromycin. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9333032
|
Wolinsky E |
Mycobacterium avium strains resistant to clarithromycin and azithromycin. |
1994 |
Antimicrob. Agents Chemother. |
pmid:8031406
|
Azoulay-Dupuis E et al. |
Prophylactic and therapeutic activities of azithromycin in a mouse model of pneumococcal pneumonia. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1656849
|
Amacher DE et al. |
Comparison of the effects of the new azalide antibiotic, azithromycin, and erythromycin estolate on rat liver cytochrome P-450. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1656856
|
Perronne C et al. |
Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1656860
|
Araujo FG and Remington JS |
Synergistic activity of azithromycin and gamma interferon in murine toxoplasmosis. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1656872
|
Fass RJ |
Erythromycin, clarithromycin, and azithromycin: use of frequency distribution curves, scattergrams, and regression analyses to compare in vitro activities and describe cross-resistance. |
1993 |
Antimicrob. Agents Chemother. |
pmid:8257127
|
Taylor DE and Chang N |
In vitro susceptibilities of Campylobacter jejuni and Campylobacter coli to azithromycin and erythromycin. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1659309
|
Gunell M et al. |
In vitro activity of azithromycin against nontyphoidal Salmonella enterica. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20498312
|
Wingard JB et al. |
A novel cell-associated protection assay demonstrates the ability of certain antibiotics to protect ocular surface cell lines from subsequent clinical Staphylococcus aureus challenge. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21628536
|
Plouffe J et al. |
Clinical efficacy of intravenous followed by oral azithromycin monotherapy in hospitalized patients with community-acquired pneumonia. The Azithromycin Intravenous Clinical Trials Group. |
2000 |
Antimicrob. Agents Chemother. |
pmid:10858333
|
Skindersoe ME et al. |
Effects of antibiotics on quorum sensing in Pseudomonas aeruginosa. |
2008 |
Antimicrob. Agents Chemother. |
pmid:18644954
|
Bermudez LE et al. |
Emergence of Mycobacterium avium populations resistant to macrolides during experimental chemotherapy. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9449283
|
Roblin PM and Hammerschlag MR |
Microbiologic efficacy of azithromycin and susceptibilities to azithromycin of isolates of Chlamydia pneumoniae from adults and children with community-acquired pneumonia. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9449287
|
Spangler SK et al. |
Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococci. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9593160
|
Pene Dumitrescu T et al. |
Development of a population pharmacokinetic model to describe azithromycin whole-blood and plasma concentrations over time in healthy subjects. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23629714
|
Roblin PM and Hammerschlag MR |
In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae. |
1998 |
Antimicrob. Agents Chemother. |
pmid:9624507
|
Amsden GW et al. |
Pharmacokinetics in serum and leukocyte exposures of oral azithromycin, 1,500 milligrams, given over a 3- or 5-day period in healthy subjects. |
1999 |
Antimicrob. Agents Chemother. |
pmid:9869584
|
Gelber RH et al. |
Activities of various macrolide antibiotics against Mycobacterium leprae infection in mice. |
1991 |
Antimicrob. Agents Chemother. |
pmid:1648889
|
Woosley LN et al. |
CEM-101 activity against Gram-positive organisms. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20176910
|
Critchley IA et al. |
National and regional assessment of antimicrobial resistance among community-acquired respiratory tract pathogens identified in a 2005-2006 U.S. Faropenem surveillance study. |
2007 |
Antimicrob. Agents Chemother. |
pmid:17908940
|
Pérez-MartÃnez I and Haas D |
Azithromycin inhibits expression of the GacA-dependent small RNAs RsmY and RsmZ in Pseudomonas aeruginosa. |
2011 |
Antimicrob. Agents Chemother. |
pmid:21537014
|
Salman S et al. |
Optimal Antimalarial Dose Regimens for Sulfadoxine-Pyrimethamine with or without Azithromycin in Pregnancy Based on Population Pharmacokinetic Modeling. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28242669
|
Unemo M et al. |
High in vitro susceptibility to the novel spiropyrimidinetrione ETX0914 (AZD0914) among 873 contemporary clinical Neisseria gonorrhoeae isolates from 21 European countries from 2012 to 2014. |
2015 |
Antimicrob. Agents Chemother. |
pmid:26077246
|
Goswick SM and Brenner GM |
Activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12543653
|
Hoffman HL et al. |
Influence of macrolide susceptibility on efficacies of clarithromycin and azithromycin against Streptococcus pneumoniae in a murine lung infection model. |
2003 |
Antimicrob. Agents Chemother. |
pmid:12543686
|
Breitschwerdt EB et al. |
Efficacy of doxycycline, azithromycin, or trovafloxacin for treatment of experimental Rocky Mountain spotted fever in dogs. |
1999 |
Antimicrob. Agents Chemother. |
pmid:10103185
|
Bogdanovich T et al. |
Effect of efflux on telithromycin and macrolide susceptibility in Haemophilus influenzae. |
2006 |
Antimicrob. Agents Chemother. |
pmid:16495248
|
Lai PC and Walters JD |
Azithromycin kills invasive Aggregatibacter actinomycetemcomitans in gingival epithelial cells. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23274657
|
Sjölund Karlsson M et al. |
Outbreak of infections caused by Shigella sonnei with reduced susceptibility to azithromycin in the United States. |
2013 |
Antimicrob. Agents Chemother. |
pmid:23274665
|
Hafner R et al. |
Tolerance and pharmacokinetic interactions of rifabutin and azithromycin. |
2001 |
Antimicrob. Agents Chemother. |
pmid:11302832
|
Donati M et al. |
In vitro activities of several antimicrobial agents against recently isolated and genotyped Chlamydia trachomatis urogenital serovars D through K. |
2010 |
Antimicrob. Agents Chemother. |
pmid:20855744
|
Soares GM et al. |
Effects of azithromycin, metronidazole, amoxicillin, and metronidazole plus amoxicillin on an in vitro polymicrobial subgingival biofilm model. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25733510
|
Parry CM et al. |
Clinically and microbiologically derived azithromycin susceptibility breakpoints for Salmonella enterica serovars Typhi and Paratyphi A. |
2015 |
Antimicrob. Agents Chemother. |
pmid:25733500
|